Blog Posts

Yianni Kournoutas: 1st Line Atezolizumab/Bevacizumab vs. Tremelimumab/Durvalumab in Unresectable HCC

medicinetoday.com

Jan 27, 2025, 10:10

Yianni Kournoutas: 1st Line Atezolizumab/Bevacizumab vs. Tremelimumab/Durvalumab in Unresectable HCC

Yianni Kournoutas, Hematologist and Oncologist at Mayo Clinic shared a post on X:

“Great time at GI25, GIASCO so far! Had a blast presenting our study on 1st line atezo/bev vs. treme/durva in unresectable HCC.

Many thanks to my mentors Dr. Tran Nguyen and Dr. Ou for their support and guidance.”

cancer OncoDaily Oncology Ou Tran Nguyen Yianni Kournoutas

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Voices

Aug 23, 2025, 16:36

Jared Burks: Cancer-Induced Nerve Injury Drives Anti-PD-1 Resistance

Voices

Aug 23, 2025, 16:35

Jeff Yang: In a TV Segment About Health Screening for Women, Lung Cancer Screening Was Left Out

Dialogues

Aug 23, 2025, 16:32

Empowering Oncologists: How I pursued my journey as an IMG?

Voices

Aug 23, 2025, 16:30

Narjust Florez: On the Frontlines - Promoting Awareness of Young Lung Cancer

Science

Aug 23, 2025, 16:24

Neeraj Agarwal: Statins Linked to Better Survival in Advanced Prostate Cancer

Science

Aug 23, 2025, 16:22

Jun Kim: Neuron–tumor Interactions via Axonal Injury Fuel Early Glioblastoma Progression

Voices

Aug 23, 2025, 16:08

Victoria Wolodzko Smart: A WIN for people facing Inflammatory Breast Cancer (IBC)

Voices

Aug 23, 2025, 16:04

Stephen V Liu: Join Discussion on Treating Rare Lung Cancer Subtypes at WCLC25

Voices

Aug 23, 2025, 15:58

Free One-Day Events Across the UK for People Affected by EGFR-Positive Lung Cancer

Insight

Aug 23, 2025, 15:49

Patrick Forde: The Final Survival Results of Neoadjuvant Nivolumab in Lung Cancer

Voices

Aug 23, 2025, 15:39

David Agus: New Research and Insights on Cancer Prevention in Young Adults

Voices

Aug 23, 2025, 15:39

Mécénat Servier Fosters Social Innovation Through Lasting Partnerships and Support